Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026 | $TWST
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that it will issue its financial results for the fiscal 2026 fourth quarter and full year ended September 30, 2026, before the opening of the market on November 12, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an upd
$TWST
NASDAQ
Twist Bioscience Corporation
Market Snapshot
Delayed market data
Market data displayed by TradingView.
Market data may be delayed.
Chart
Twist Bioscience Corporation
Range
1 month
Chart loads when visible
Latest
Coverage
You are up to date.